646 related articles for article (PubMed ID: 26427840)
1. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.
Huang R; Chen Z; He L; He N; Xi Z; Li Z; Deng Y; Zeng X
Theranostics; 2017; 7(14):3559-3572. PubMed ID: 28912895
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
4. Proteomics for breast cancer urine biomarkers.
Beretov J; Wasinger VC; Graham PH; Millar EK; Kearsley JH; Li Y
Adv Clin Chem; 2014; 63():123-67. PubMed ID: 24783353
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Approaches for Biomarker Panels in Cancer.
Tanase C; Albulescu R; Neagu M
J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometry-based membrane proteomics in cancer biomarker discovery.
Mermelekas G; Zoidakis J
Expert Rev Mol Diagn; 2014 Jun; 14(5):549-63. PubMed ID: 24820261
[TBL] [Abstract][Full Text] [Related]
7. Biomarker discovery in mass spectrometry-based urinary proteomics.
Thomas S; Hao L; Ricke WA; Li L
Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953
[TBL] [Abstract][Full Text] [Related]
8. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
Fredolini C; Liotta LA; Petricoin EF
Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
[TBL] [Abstract][Full Text] [Related]
9. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
Ménard C; Johann D; Lowenthal M; Muanza T; Sproull M; Ross S; Gulley J; Petricoin E; Coleman CN; Whiteley G; Liotta L; Camphausen K
Cancer Res; 2006 Feb; 66(3):1844-50. PubMed ID: 16452246
[TBL] [Abstract][Full Text] [Related]
10. Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy.
Deng J; Wang L; Ni J; Beretov J; Wasinger V; Wu D; Duan W; Graham P; Li Y
Expert Rev Proteomics; 2016 Oct; 13(10):905-915. PubMed ID: 27598304
[TBL] [Abstract][Full Text] [Related]
11. Targeted mass spectrometry approaches for protein biomarker verification.
Meng Z; Veenstra TD
J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
[TBL] [Abstract][Full Text] [Related]
12. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
13. Protein mass spectra data analysis for clinical biomarker discovery: a global review.
Roy P; Truntzer C; Maucort-Boulch D; Jouve T; Molinari N
Brief Bioinform; 2011 Mar; 12(2):176-86. PubMed ID: 20534688
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
Ma H; Chen G; Guo M
Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry as a tool for biomarkers searching in gynecological oncology.
Banach P; Suchy W; Dereziński P; Matysiak J; Kokot ZJ; Nowak-Markwitz E
Biomed Pharmacother; 2017 Aug; 92():836-842. PubMed ID: 28601044
[TBL] [Abstract][Full Text] [Related]
16. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
17. Proteomic biomarker discovery: it's more than just mass spectrometry.
Blonder J; Issaq HJ; Veenstra TD
Electrophoresis; 2011 Jun; 32(13):1541-8. PubMed ID: 21557261
[TBL] [Abstract][Full Text] [Related]
18. Oncoproteomics: current trends and future perspectives.
Cho WC; Cheng CH
Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
[TBL] [Abstract][Full Text] [Related]
19. Combining bioinformatics and MS-based proteomics: clinical implications.
Acosta-Martin AE; Lane L
Expert Rev Proteomics; 2014 Jun; 11(3):269-84. PubMed ID: 24720436
[TBL] [Abstract][Full Text] [Related]
20. Optomechanical devices for deep plasma cancer proteomics.
Kosaka PM; Calleja M; Tamayo J
Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
